1. Home
  2. SYPR vs TIL Comparison

SYPR vs TIL Comparison

Compare SYPR & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SYPR

Sypris Solutions Inc.

HOLD

Current Price

$1.81

Market Cap

47.4M

Sector

Industrials

ML Signal

HOLD

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$7.57

Market Cap

52.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYPR
TIL
Founded
1997
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
52.2M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SYPR
TIL
Price
$1.81
$7.57
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
26.8K
5.6K
Earning Date
05-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.06
EPS
N/A
N/A
Revenue
$82,294,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$5.67
52 Week High
$4.74
$26.48

Technical Indicators

Market Signals
Indicator
SYPR
TIL
Relative Strength Index (RSI) 45.98 51.14
Support Level $1.79 $7.43
Resistance Level $2.09 $7.99
Average True Range (ATR) 0.10 0.21
MACD 0.02 -0.00
Stochastic Oscillator 56.25 43.86

Price Performance

Historical Comparison
SYPR
TIL

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc provides products and engineering, design, and manufacturing services for a variety of critical infrastructure sectors, including energy, space, communications, defense, transport, chemical, and water. The company operates in two segments, Sypris Technologies and Sypris Electronics. Sypris Technologies segment includes the sale of forged, machined, welded and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications, whereas the Sypris Electronics segment includes revenue from circuit card and box build manufacturing, high reliability manufacturing and systems assembly and integration, for aerospace and defense, communications and space applications. The majority of revenue is derived from the Sypris Electronics segment.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: